Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Accounts Payables: 2017-2018

Historic Accounts Payables for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $1.4 million.

  • Astria Therapeutics' Accounts Payables rose 105.92% to $2.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was $2.2 million, marking a year-over-year increase of 105.92%. This contributed to the annual value of $1.4 million for FY2018, which is 82.15% up from last year.
  • Astria Therapeutics' Accounts Payables amounted to $1.4 million in FY2018, which was up 82.15% from $773,000 recorded in FY2017.
  • Astria Therapeutics' 5-year Accounts Payables high stood at $1.4 million for FY2018, and its period low was $773,000 during FY2017.
  • Its 2-year average for Accounts Payables is $1.1 million, with a median of $1.1 million in 2017.
  • Data for Astria Therapeutics' Accounts Payables shows a peak YoY soared of 82.15% (in 2018) over the last 5 years.
  • Over the past 2 years, Astria Therapeutics' Accounts Payables (Yearly) stood at $773,000 in 2017, then surged by 82.15% to $1.4 million in 2018.